In line with the mRNA expression, IHC showed that Cxcl2 was abundantly expressed in non-tumor cells of a-PD-L1- and IgG-treated Egfl6-2F8c tumors compared to their control 2F8c tumors (Figure 4G). This evidence concerns the gene CXCL2 and neoplasm.